Lumipulse® G HBsAg-Quant
Immunoreaction cartridges for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the qualitative and quantitative detection of hepatitis B surface antigen (HBsAg) in human serum or plasma.
This product is indicated as an aid for screening and diagnosis of hepatitis B viral infection and for professional use only.
The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
Product number 296851
Click here to navigate
- Details
- Conditions of sale
- Documentation
- FAQ
- Insights
- Related products
- Product inquiry
-
Details
Assay technology
CLEIA - ChemiLuminescent Enzyme Immunoassay
See the LUMIPULSE G1200 working in this video:
-
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Other documents
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
In March 2017 the European Association for the Study of the Liver (EASL) added a new serological marker, HBcrAg (Hepatitis B core-related antigen), to...
Jul 10, 2019
-
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?
Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry